Thymalin
A natural thymus peptide complex that restores thymic function and immune competence - particularly studied for immune reconstitution in ageing and immunodeficiency.
⚠ Research & Educational Use Only. Thymalin is a research chemical documented here for scientific education. All information references peer-reviewed literature and preclinical/clinical study data. Not for human consumption. Not medical advice. Consult a licensed researcher or healthcare professional before any laboratory use.
- Restores thymic function and T-cell production in age-related thymic involution
- Increases peripheral T-lymphocyte counts - CD4+ and CD8+ subsets in ageing and immunocompromised models
- Enhances natural killer (NK) cell activity and cytokine production
- Thymalin is not FDA-approved for human use. It is a research chemical for scientific study only.
Research At a Glance
- Restores thymic function and T-cell production in age-related thymic involution
- Increases peripheral T-lymphocyte counts - CD4+ and CD8+ subsets in ageing and immunocompromised models
- Enhances natural killer (NK) cell activity and cytokine production
- Reduces cortisol-mediated immunosuppression in stress models
What is Thymalin?
Thymalin is a natural polypeptide complex isolated from the thymus gland of cattle, developed by the St. Petersburg Institute of Biogerontology in Russia during the 1970s-80s. It was part of a pioneering research program into the biological role of thymic peptides in immune regulation and ageing, led by Professor Vladimir Khavinson (who also developed Epithalon, Cortagen, and other bioregulators).
The thymus is the primary training ground for T-lymphocytes - the adaptive immune cells that orchestrate specific immune responses. The thymus is largest and most active in childhood and adolescence, then progressively involutes (shrinks and loses function) from puberty onwards. By age 40-50, thymic output has declined dramatically, contributing to the well-documented decline in immune competence with ageing (immunosenescence). This thymic involution is associated with reduced numbers and diversity of naive T-cells, impaired vaccine responses, increased susceptibility to infection, and potentially reduced immune surveillance against cancer.
Thymalin contains a mixture of small bioactive polypeptides that mimic the immunomodulatory signals normally produced by thymic epithelial cells. These signals normally direct the maturation, selection, and export of T-cells. By providing these signals exogenously, Thymalin aims to support or restore thymic function and peripheral T-cell reconstitution.
The most compelling published data on Thymalin comes from a long-running Russian geriatric study. Elderly subjects (65-80 years old) treated with Thymalin twice-yearly for 8 years showed significantly reduced all-cause mortality compared to the control group, improved immune parameters, and better functional health outcomes. While methodological questions about this research remain (as with much Russian peptide bioregulator research), the clinical observations have sustained interest in thymic peptide biology as a longevity intervention.
Thymalin is closely related to but distinct from Thymosin Alpha-1 (Ta1, marketed as Zadaxin) - which is a single, defined 28-amino acid peptide. Thymalin is a more complex, less defined polypeptide mixture, more analogous to how a natural extract differs from a purified compound.
Key Research Benefits
Documented effects observed in preclinical and clinical studies on Thymalin. See all Immune System peptides for comparison.
Common Stacks
Thymalin is frequently combined with the following peptides for synergistic effects. Click any peptide to compare profiles before deciding.
IGF-1 DES (short-acting, site-specific) and IGF-1 LR3 (long-acting, systemic) can be combined for both localised and systemic anabolic IGF-1 signalling.
CJC-1295 drives endogenous GH/IGF-1 while IGF-1 DES provides direct, immediate post-workout receptor activation in target muscles.
Side Effects & Risks
Adverse effects reported in the research literature. All data sourced from preclinical and clinical study reports.
Dosing Data from the Literature
Doses referenced below are sourced from published preclinical and clinical studies. Use the peptide dose calculator to convert these values to injection volume.
Thymalin research protocols from Russian longevity studies used 10 mg/day for 10 consecutive days, repeated twice yearly.
Standard research protocol: 10 mg IM or SC daily for 10 days Maintenance: repeat course twice per year Some protocols use 5 mg/day for 10 days for mild immunostimulation Monitor CBC and lymphocyte subsets to track immune reconstitution
Administration in Research Settings
Standard reconstitution and administration methodology for laboratory research use.
Reconstitute Thymalin powder with physiological saline or bacteriostatic water. Administer intramuscularly or subcutaneously once daily for 10 consecutive days. The 10-day course is a standard Russian bioregulator protocol.
Explore Further
Quick Reference
Research Use Only
This information is for educational research purposes only. This is not medical advice. Consult a qualified healthcare professional.